287 | To find | theellasmith | 10/09/2012 3:51:50 AM |
286 | These a | theellasmith | 10/09/2012 3:47:33 AM |
285 | I prefe | Mary Johnson | 10/09/2012 3:40:33 AM |
284 | Short,medium or long run?However success is | Mary Johnson | 10/09/2012 3:16:00 AM |
283 | Exactly | mwirmm | 10/08/2012 4:04:57 PM |
282 | The definition of the market on which UWRL is | Milly Joel | 10/08/2012 4:01:08 PM |
281 | Nice, t | mwirmm | 10/08/2012 3:44:22 PM |
280 | +7650% Techn | Milly Joel | 10/08/2012 3:40:07 PM |
279 | Excitin | mwirmm | 10/08/2012 3:38:26 PM |
278 | UWRL ha | mwirmm | 10/08/2012 3:38:21 PM |
277 | We'll g | judith keenan | 10/08/2012 1:41:20 PM |
276 | I agree | judith keenan | 10/08/2012 1:09:45 PM |
275 | I hopetheylaunchnews site that would give | judith keenan | 10/08/2012 12:59:55 PM |
274 | Will watch UWRL with interest, looking for | judith keenan | 10/08/2012 12:32:26 PM |
273 | Well, i | judith keenan | 10/08/2012 12:25:52 PM |
272 | I'm expecting a big spike ! | John Howard | 10/08/2012 11:38:27 AM |
271 | UWRL ha | John Howard | 10/08/2012 11:34:58 AM |
270 | UWRL BUY! | John Howard | 10/08/2012 11:32:00 AM |
269 | Update: | aleksdavis | 10/08/2012 7:36:49 AM |
268 | Some in | theellasmith | 10/08/2012 7:29:05 AM |
267 | Expectations for this week? Your opinion about | aleksdavis | 10/08/2012 7:16:29 AM |
266 | Well, U | aleksdavis | 10/08/2012 7:10:40 AM |
265 | That's | theellasmith | 10/08/2012 7:02:48 AM |
264 | Ofc. Re | aleksdavis | 10/08/2012 7:02:20 AM |
263 | Check t | theellasmith | 10/08/2012 6:58:47 AM |
262 | Such a | aleksdavis | 10/08/2012 6:57:45 AM |
261 | Why ent | theellasmith | 10/08/2012 6:53:54 AM |
260 | UWRL | judith keenan | 10/05/2012 1:15:21 PM |
259 | It would be great to see news out but you should | judith keenan | 10/05/2012 1:09:52 PM |
258 | I'm pretty sure UW | judith keenan | 10/05/2012 12:42:07 PM |
257 | They've | judith keenan | 10/05/2012 12:30:11 PM |
256 | I agree | judith keenan | 10/05/2012 12:25:02 PM |
255 | This week UWRL didn't do very well | judith keenan | 10/05/2012 12:14:24 PM |
254 | Uwrl is | Mary Johnson | 10/05/2012 11:32:37 AM |
253 | I must | theellasmith | 10/05/2012 11:08:24 AM |
252 | Everyth | theellasmith | 10/05/2012 11:06:06 AM |
251 | Have you seen some stats on the Forex market? The | theellasmith | 10/05/2012 11:03:22 AM |
250 | TrendSp | theellasmith | 10/05/2012 11:01:23 AM |
249 | Seems l | Mary Johnson | 10/05/2012 10:40:32 AM |
248 | Imo con | Mary Johnson | 10/05/2012 10:34:11 AM |
247 | You are | Mary Johnson | 10/05/2012 10:25:49 AM |
246 | Hello everybody ...Just to remind you that 2day | Mary Johnson | 10/05/2012 10:21:42 AM |
245 | Looking | mwirmm | 10/05/2012 7:22:16 AM |
244 | UWRL plans | mwirmm | 10/05/2012 7:15:41 AM |
243 | Lots of | mwirmm | 10/05/2012 7:14:44 AM |
242 | Its bee | mwirmm | 10/05/2012 7:12:27 AM |
241 | Nice no | mwirmm | 10/05/2012 7:11:40 AM |
240 | Crossed my fingers for that | Milly Joel | 10/05/2012 6:45:54 AM |
239 | I think | John Howard | 10/05/2012 6:41:26 AM |
238 | Same thoughts here, hope to see green closure | Milly Joel | 10/05/2012 6:39:31 AM |
Recent Articles
- Established Tech Giants Poised to Lead in AI Development
- ENGWE's Innovative Journey: Connecting E-Bike Riders Worldwide
- Investigation Ongoing After Daring Jewelry Heist at Louvre
- Unveiling Sustainable Solutions: Insights from Global Leaders
- SKYWORTH Launches Revolutionary Matte Screen Ultra TV Series
- Exciting Advances in Lung Cancer Treatment with Sacituzumab Tirumotecan
- MoonLake Immunotherapeutics: A Call to Action for Investors
- Investors Urged to Act Quickly in PubMatic Class Action Suit
- Tragic Cargo Plane Incident at Hong Kong Airport Sparks Concerns
- Christine Lagarde's Insight: Upcoming Tariff Effects on U.S. Consumers
- Insights on the Upcoming Financial Street Forum in Beijing
- Antengene Advances ATG-022: Promising Clinical Outcomes Revealed
- Investigation Announcement for Baxter International Investors
- Cytokinetics Investors: Secure Representation Before Deadline
- Jasper Therapeutics Investors: Important Class Action Deadline Ahead
- Mesoblast Limited Reports Significant Revenue Growth After Ryoncil Launch
- CStone Pharmaceuticals Shares Promising Phase I Results for CS2009
- Ascletis Completes Enrollment in Phase IIa Study of ASC30.
- Innovations in Pancreatic Cancer Treatment with Satri-cel
- Cambodia's Techo International Airport: A Gateway to Growth
- Record Growth in Q2 Revenues Enhances Mesoblast's Market Position
- Faraday Future's Vision: Accelerating Towards FX Super One Launch
- IZERVAY™ Delivers Long-Term Benefits for Geographic Atrophy Patients
- Clover Biopharmaceuticals Names Nicholas Jackson as President
- Dr. Luke Wainscoat Brings Expertise to The Brattle Group
- Kering and L'Oréal Unite to Transform Luxury Beauty Sector
- Kering and L’Oréal: A New Era in Luxury Beauty and Wellness
- Kering Partners with L'Oréal to Transform Luxury Beauty Sector
- Alice Walton and Elon Musk: Giants of Wealth in 2025
- Clarins and V Magazine Host a Glamorous Golden Hour Event
- Sobi Adjusts Revenue Forecast for 2025 Amid Strong Q3 Growth
- Sobi Updates Full-Year Outlook and Q3 2025 Financial Report
- Exploring NB HASH and the Transformation of Wealth Today
- Kevin Hart's Journey From Investment Missteps to Business Success
- BlackRock's Strategic Shift: The Future of Investment in RWA
- Major Contract Termination Announced by Vantage Drilling
- Deadline Approaches for Dow Inc. Investors Amid Legal Action
- Important Update for Cepton, Inc. Investors on Class Action
- Target and Walmart Thrive Amid Collectible Card Sales Surge
- Snap Investors Urged to Consider Leading Legal Action
- Unlocking Wealth Potential: The RWA Revolution Explained
- Embracing Real-World Assets with NB HASH for Sustainable Growth
- Nutex Health Investors Can Join Class Action Against Company
- Potential Legal Action for Baxter International Investors
- Solidarity in Aviation: Airline Workers Support Controllers
- Class Action Lawsuit Against MoonLake Immunotherapeutics Investors
- Promising Outcomes Unveiled from HARMONi-6 Clinical Study
- Exploring Cadonilimab's Promising Results in Advanced Gastric Cancer
- Tech Giants Reshape Manufacturing Strategies Amid Market Shifts
- Promising Findings on Subcutaneous Amivantamab for Cancer